FROM A POSITIVE AUTOANTIBODY TO AUTOIMMUNE DISEASE: WHAT DOES THE EVIDENCE SHOW FOLLOWING VIRAL INFECTIONS?
Authors:
- Anna Gwóźdź-BroczkowskaAGAnna Gwóźdź-Broczkowska
- Agata KotłowskaAKAgata Kotłowska
- Julia LenkiewiczJLJulia Lenkiewicz
- Aleksandra Izabela MasłowskaAMAleksandra Izabela Masłowska
- Wiktoria NapiórkowskaWNWiktoria Napiórkowska
- Gabriela LubaGLGabriela Luba
- Marcin TrzcińskiMTMarcin Trzciński
- Oliwia LenkiewiczOLOliwia Lenkiewicz
Open Access
- 7 September 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Abstract
Autoantibodies are commonly detected during or shortly after viral illness, sometimes in patients whose presentation already resembles a systemic or organ-specific autoimmune disorder. The difficulty is that the laboratory finding often arrives before the clinical meaning of that finding is clear. In acute parvovirus B19 and hepatitis E, ANA, RF or autoimmune liver serology may accompany the infection and then recede as the illness resolves. SARS-CoV-2 cohorts that include pre-infection samples show that genuine seroconversion can occur, but they also expose a separate problem: a newly detectable or persistent autoantibody is not the same endpoint as clinically defined autoimmune disease. HCV-associated cryoglobulinaemic vasculitis is different because infection, immune-complex formation and organ disease belong to the same pathogenic process. Across the other viral settings, interpretation is limited by referral bias, incomplete follow-up, assay heterogeneity and the frequent use of serological rather than clinical endpoints. Taken together, the recent literature supports post-viral autoreactivity far more consistently than it supports frequent progression to a new autoimmune disease. Diagnostic weight increases when the antibody is disease-concordant, persists beyond the acute infection and accompanies an objective phenotype that the infection no longer adequately explains.Keywords
This publication has 46 references indexed in Scilit:
- The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response CriteriaArthritis & Rheumatology, 2026
- Rheumatic manifestations of HIV/AIDSBest Practice & Research Clinical Rheumatology, 2025
- Zika and Dengue Virus Autoimmunity: An Overview of Related Disorders and Their Potential MechanismsReviews in Medical Virology, 2025
- Role of auto-antibodies in the mechanisms of dengue pathogenesis and its progression: a comprehensive reviewArchives of Microbiology, 2024
- The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaArthritis & Rheumatology, 2023
- Increasing Prevalence of Antinuclear Antibodies in the United StatesArthritis & Rheumatology, 2022
- Autoimmune liver disease-associated serologic profiling in Chinese patients with acute hepatitis E virus infectionImmunologic Research, 2021
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- Prospective study of guideline‐tailored therapy with direct‐acting antivirals for hepatitis C virus‐associated mixed cryoglobulinemiaHepatology, 2016
- Prevalence of Post‐Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta‐AnalysisArthritis Care & Research, 2016